Quarterly report [Sections 13 or 15(d)]

CONDENSED INTERIM STATEMENTS OF CASH FLOWS

v3.26.3
CONDENSED INTERIM STATEMENTS OF CASH FLOWS - USD ($)
 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Cash Flows from Operating Activities:    
Net Loss $ (6,518,727) $ (6,388,262)
Adjustments to Reconcile Net Loss to Net Cash Used in Operating Activities:    
Share-Based Compensation 666,993 952,607
Share-Based Payments to Vendors 222,999 241,319
(Increase)/Decrease in:    
Other Receivable 6,290 10,919
Prepaid Expenses (555,590) (58,078)
Accounts Payable and Accrued Expenses 572,295 (361,547)
Net Cash Used in Operating Activities (5,605,740) (5,603,042)
Cash Flows from Financing Activities:    
Proceeds from issuance of common stock in connection with equity line of credit purchase agreement, net of issuance costs 5,432,314 2,334,945
Proceeds from 2026 April Registered Direct Offering, net of issuance costs 2,271,858  
Proceeds from 2025 March Registered Direct Offering, net of issuance costs   889,420
Proceeds from 2025 January Registered Direct Offering, net of issuance costs   2,099,253
Proceeds from 2025 Warrant Exercise, net of issuance costs   2,480,553
Reverse Stock Split fractional share adjustment   (1,040)
Net Cash Provided by Financing Activities 7,704,172 7,803,131
Net Increase in Cash 2,098,432 2,200,089
Cash at Beginning of Period 7,556,100 3,706,713
Cash at End of Period $ 9,654,532 5,906,802
SUPPLEMENTAL DISCLOSURE OF NON-CASH OPERATING ACTIVITIES    
Share-Based Compensation to settle accrued compensation (Note 5)   413,120
SUPPLEMENTAL DISCLOSURE OF NON-CASH FINANCING ACTIVITIES    
2025 Equity Line of Credit Purchase Agreement costs (Commitment shares) (Note 4)   360,000
2025 Warrant Inducement Financing cost (Note 4)   4,636,869
2025 January Registered Direct Offering costs (Note 4)   85,419
2025 March Registered Direct Offering costs (Note 4)   $ 56,163